Lumos Pharma Inc logo

Lumos Pharma Inc

FRA:4NX1 (USA)  
(Delisted) € 7.20 (+8.27%) Aug 18
At Loss
P/B:
0.78
Market Cap:
€ 55.76M ($ 59.40M)
Enterprise V:
€ 16.57M ($ -15.04M)
Volume:
-
Avg Vol (2M):
-
Market Cap € M 55.76
Enterprise Value € M 16.57
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 0.78
Price/Sales 7.82
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) € M 2.00
EPS (TTM) € --
Beneish M-Score 0
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % 20.10
y-y EBITDA Growth Rate % --
EV-to-EBIT 0.32
EV-to-EBITDA 0.32
PEG --
Shares Outstanding M 8.36
Net Margin (%) -1,509.12
Operating Margin % -1,628.34
Pre-tax Margin (%) -1,510.18
Quick Ratio 5.69
Current Ratio 5.69
ROA % (ttm) -73.69
ROE % (ttm) -94.66
ROIC % (ttm) -1,280.65
Dividend Yield % --
Altman Z-Score -6.93
Piotroski F-Score 3.00
Positive ROA N
Positive CFROA N
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y N
Higher Current Ratio y-y N
Less Shares Outstanding y-y Y
Gross Margin Increase y-y N
Higher Asset Turnover y-y Y

FRA:4NX1 Number of Guru Trades

To

FRA:4NX1 Volume of Guru Trades

To

Gurus Latest Trades with FRA:4NX1

No Available Data

FRA:4NX1 is held by these investors

No Available Data